Moderated by Scott Henry, Managing Director, Senior Research Analyst & Head of Pharmaceuticals Research at ROTH Capital Partners, LLC, will conduct a fireside chat with Mr. Bagai, who will discuss recent Company milestones, including the research collaboration with Imugene (ASX: IMU), and highlights from RenovoRx’s open label pivotal Phase III TIGeR- PaC study.
ROTH MKM Healthcare Opportunities Conference
Date: October 12, 2023Time: 11:30 AM Speaker: Shaun Bagai, CEO
Go to Renovo's website to register if interested
- Forums
- ASX - By Stock
- Why IMU is a multi multi bagger
Moderated by Scott Henry, Managing Director, Senior Research...
-
- There are more pages in this discussion • 8,895 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
|
|||||
Last
5.5¢ |
Change
-0.001(1.79%) |
Mkt cap ! $404.2M |
Open | High | Low | Value | Volume |
5.5¢ | 5.6¢ | 5.4¢ | $757.1K | 13.81M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
16 | 2203877 | 5.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.5¢ | 244428 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
16 | 2203877 | 0.054 |
24 | 3523105 | 0.053 |
21 | 1966792 | 0.052 |
18 | 1595967 | 0.051 |
64 | 5239130 | 0.050 |
Price($) | Vol. | No. |
---|---|---|
0.055 | 244428 | 4 |
0.056 | 606122 | 6 |
0.057 | 1272468 | 9 |
0.058 | 419109 | 6 |
0.059 | 475000 | 4 |
Last trade - 16.10pm 25/07/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |